Long-term Clinical and Cost Outcomes of a Pharmacist-managed Risk Factor Management Clinic in Singapore: An Observational Study

Tan, She Hui; Kng, Kwee Keng; Lim, Sze Mian; Chan, Alexandre; Loh, Jason Kwok Kong; Lee, Joyce Yu‐Chia

doi:10.1016/j.clinthera.2017.10.009

Cited by 3 publications

(1 citation statement)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…An observational study of a pharmacist-led risk factor management clinic examined the cost impact of pharmacists managing patients with type II diabetes, compared to patients managed through other clinics. Although the drug costs for the intervention group were slightly higher, a nearly 8-fold savings was realized from decreased inpatient hospitalizations (mean inpatient costs of US$6,793 vs. US$53,499 for those with usual care; Tan et al, 2017). Considering the challenges and costs in providing care outside of the prisons, a reduction in inpatient hospital visits would have a large potential impact on the overall health care costs (Office of the Inspector General, 2015).…”

Section: Review Of the Literaturementioning

confidence: 92%

Clinical Pharmacists in Correctional Facilities: A Literature Review and Future Directions

Thomson

Gunther

Macek

2019

Journal of Correctional Health Care

View full text Add to dashboard Cite

The role of pharmacists has undergone a significant transformation. Expanding clinical roles in the community and hospital settings have led to opportunity for correctional facility pharmacists to expand their practice. This literature review identifies past and present roles of correctional pharmacists, along with areas for growth. Peer-reviewed and gray literature is described, outlining current and expanding pharmacist roles from 1997 to 2017. The literature reveals that health care provided in correctional facilities is shifting from a basic level of care to a greater role in inmate health and identifies the challenges and barriers that pharmacists meet. There is strong evidence to support the expanding role of pharmacists as primary care providers in the corrections setting through activities such as direct patient care, health care clinics, and medication management.

show abstract

Section: Review Of the Literaturementioning

confidence: 92%

Clinical Pharmacists in Correctional Facilities: A Literature Review and Future Directions

Thomson

Gunther

Macek

2019

Journal of Correctional Health Care

View full text Add to dashboard Cite

show abstract

The impact of pharmacist care on diabetes outcomes in primary care settings: An umbrella review of published systematic reviews

Abdulrhim

Sankaralingam

Ibrahim

et al. 2020

Primary Care Diabetes

View full text Add to dashboard Cite

Clinical activities that contributed to the effectiveness of a cardiologist–pharmacist collaborative care model in managing diabetes

Lum

Kng

Goh

et al. 2023

International Journal of Pharmacy Practice

View full text Add to dashboard Cite

Objectives The primary objectives of this study were to evaluate the change in glycated haemoglobin (HbA1c) and its association to clinical activities. The secondary objective was to elucidate moderators of the relationship between pharmacist-involved collaborative care (PCC) and change in HbA1c. Methods This study was a retrospective cohort study conducted in a tertiary hospital over 12 months. Individuals with Type 2 diabetes, aged ≥21 years with established cardiovascular diseases were included while individuals with incomplete care documentation or missing data related to cardiovascular diseases were excluded. Individuals under the care of PCC were matched 1:1 based on baseline HbA1c with an eligible person who received care from the cardiologists (CC). Changes in mean HbA1c were analysed using linear mixed model. Linear regression was used to determine clinical activities that associated with improvement in HbA1c. Moderation analyses were conducted using the MacArthur framework. Key findings A total of 420 participants (PCC:210, CC:210) were analysed. The mean age of the participants was 65.6 ± 11.1 years, with the majority being male and Chinese. The mean HbA1c among participants in the PCC group decreased significantly after 6 months (PCC: −0.4% versus CC: −0.1%, P = 0.016), with maintenance of improvement at 12 months (PCC: −0.4% versus CC: −0.2%, P < 0.001). Frequencies of lifestyle counselling, reinforcement of visits to healthcare providers, health education, resolution of drug-related problems, emphasis on medication adherence, dose adjustments and advice on self-care techniques were significantly higher in the intervention group (P < 0.001). Conclusion Improvements in HbA1c were associated with the provision of health education and medication adjustments.

show abstract

Long-term Clinical and Cost Outcomes of a Pharmacist-managed Risk Factor Management Clinic in Singapore: An Observational Study

Abstract: The pharmacist-managed RFMP exhibited improved clinical outcomes and reduced health care costs compared with usual care within a tertiary institute.

Cited by 3 publications

References 26 publications

Clinical Pharmacists in Correctional Facilities: A Literature Review and Future Directions

Clinical Pharmacists in Correctional Facilities: A Literature Review and Future Directions

The impact of pharmacist care on diabetes outcomes in primary care settings: An umbrella review of published systematic reviews

Clinical activities that contributed to the effectiveness of a cardiologist–pharmacist collaborative care model in managing diabetes

Contact Info

Product

Resources

About